Yc. Lee et al., NMR conformational analysis of cis and trans proline isomers in the neutrophil chemoattractant, N-acetyl-proline-glycine-proline, BIOPOLYMERS, 58(6), 2001, pp. 548-561
Alkaline hydrolysis of corneal proteins in the alkali-injured eye releases
N-acetyl-proline-glycine-proline (Ac-Pro-Gly-Pro-OH) among other peptides.
II has been shown that this tripeptide Is a neutrophil chemoattractant. Exi
sting data suggest that the release of this peptide is the catalytic event
for early neutrophil invasion of the cornea leading to corneal ulcers. In o
rder to design inhibitors of this tripeptide chemoattractant that would blo
ck neutrophil invasion and diminish corneal ulcers, we studied the solution
properties of this tripeptide by NMR spectroscopy and compared this peptid
e to Ac-Pro-Gly-OH (a weaker chemoattractant), and to Ac-Pro-OH (inactive).
The NMR data were consistent with Ac-Pro-Gly-Pro-OH existing in solution a
s a mixture of four isomers with different cis and trans conformations abou
t the two X-proline amide bonds. The isomer with two trans conformations (t
rans-trans) was the most dominant (41%) in aqueous solution. This was follo
wed by the isomers with mixed cis and trans conformations (trans-cis, 26% a
nd cis-trans. 20%). The isomer with two cis conformations (cis-cis) was the
least Savored (13%). The populations of these these isomers were investiga
ted in DMSO and they were similar to those reported in aqueous solutions ex
cept that the ordering of the trans-cis and cis-trans isomers were reversed
. NMR NH temperature coefficients and nuclear Overhauser effect (NOE) measu
rements as well as CD spectroscopy were used to demonstrate that the four i
somers exist primarily in an extended conformation with little hydrogen bon
ding. The available (NOE) information M as used with molecular dynamics cal
culations to construct a dominant solution conformation for each isomer of
the tripeptide. This information will serve as a model for the design of pe
ptide and nonpeptide inhibitors of the chemoattractant. (C) 2001 John Wiley
& Sons, Inc.